$976 Million is the total value of First Light Asset Management, LLC's 60 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Sell | IMMUNOMEDICS INC | $134,167,000 | +126.9% | 1,577,880 | -5.4% | 13.75% | +99.5% |
| SPNE | Sell | SEASPINE HOLDINGS CORP | $73,005,000 | +36.4% | 5,105,237 | -0.2% | 7.48% | +19.9% |
| CDNA | Buy | CAREDX INC | $71,715,000 | +51.9% | 1,890,213 | +41.8% | 7.35% | +33.5% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $54,279,000 | -9.7% | 4,639,199 | +0.3% | 5.56% | -20.6% |
| KRMD | Sell | REPRO-MED SYSTEMS INC | $52,397,000 | -22.5% | 7,257,266 | -3.6% | 5.37% | -31.9% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $50,110,000 | +28.1% | 1,906,789 | +30.7% | 5.13% | +12.7% |
| INSM | Buy | INSMED INC | $32,954,000 | +16.8% | 1,025,341 | +0.1% | 3.38% | +2.7% |
| MODN | Sell | MODEL N INC | $32,880,000 | +0.8% | 931,967 | -0.7% | 3.37% | -11.3% |
| GKOS | Sell | GLAUKOS CORPORATION | $32,202,000 | +28.7% | 650,289 | -0.1% | 3.30% | +13.2% |
| OMCL | New | OMNICELL INC | $31,384,000 | – | 420,354 | +100.0% | 3.22% | – |
| TNDM | Sell | TANDEM DIABETES CARE INC | $29,193,000 | +5.3% | 257,205 | -8.3% | 2.99% | -7.4% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $23,349,000 | -11.0% | 608,193 | +0.1% | 2.39% | -21.8% |
| NEO | Buy | NEOGENOMICS INC | $22,617,000 | +19.2% | 613,102 | +0.1% | 2.32% | +4.7% |
| ATRC | Buy | ATRICURE INC | $22,385,000 | -7.7% | 561,018 | +3.9% | 2.29% | -18.9% |
| GMAB | Buy | GENMAB AS | $22,108,000 | +9.4% | 603,870 | +1.3% | 2.26% | -3.8% |
| AXGN | New | AXOGEN INC | $20,113,000 | – | 1,729,435 | +100.0% | 2.06% | – |
| KRYS | Buy | KRYSTAL BIOTECH INC | $20,004,000 | +4.0% | 464,663 | +0.1% | 2.05% | -8.5% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $19,845,000 | +18.9% | 265,339 | +0.1% | 2.03% | +4.6% |
| XENT | Buy | INTERSECT ENT INC | $19,385,000 | +20.6% | 1,188,534 | +0.1% | 1.99% | +6.0% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $16,759,000 | -34.8% | 1,860,025 | -10.8% | 1.72% | -42.7% |
| SIBN | Sell | SI-BONE INC | $15,872,000 | +48.7% | 669,120 | -0.1% | 1.63% | +30.8% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $15,203,000 | -18.0% | 184,970 | -21.9% | 1.56% | -27.9% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INC | $12,508,000 | – | 290,487 | +100.0% | 1.28% | – |
| QDEL | Buy | QUIDEL CORP | $12,445,000 | +41.4% | 56,728 | +44.2% | 1.28% | +24.3% |
| OPRX | OPTIMIZERX CORP | $12,302,000 | +60.0% | 590,000 | 0.0% | 1.26% | +40.6% | |
| MEIP | New | MEI PHARMA INC | $11,743,000 | – | 3,763,804 | +100.0% | 1.20% | – |
| CDXS | Sell | CODEXIS INC | $11,628,000 | -12.7% | 990,458 | -15.2% | 1.19% | -23.2% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $10,288,000 | +94.7% | 224,042 | +85.5% | 1.05% | +71.1% |
| KRTX | New | KARUNA THERAPEUTICS INC | $9,912,000 | – | 128,200 | +100.0% | 1.02% | – |
| AMRN | Buy | AMARIN CORPORATION | $9,414,000 | +26.5% | 2,236,158 | +107.9% | 0.96% | +11.3% |
| MYOK | Buy | MYOKARDIA INC | $9,224,000 | +41.1% | 67,662 | +0.0% | 0.94% | +24.0% |
| HCAT | Buy | HEALTH CATALYST INC | $9,178,000 | +25.7% | 250,753 | +0.1% | 0.94% | +10.5% |
| ZYME | Sell | ZYMEWORKS INC | $9,082,000 | -47.2% | 194,967 | -59.1% | 0.93% | -53.5% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $7,296,000 | – | 51,166 | +100.0% | 0.75% | – |
| VAPO | Buy | VAPOTHERM INC | $5,468,000 | -29.2% | 188,541 | +0.1% | 0.56% | -37.8% |
| SLP | Sell | SIMULATIONS PLUS INC | $5,338,000 | -28.0% | 70,831 | -42.9% | 0.55% | -36.7% |
| TPTX | Sell | TURNING POINT THERAPEUTICS | $4,790,000 | -61.5% | 54,833 | -71.6% | 0.49% | -66.2% |
| HGEN | New | HUMANIGEN INC | $4,256,000 | – | 400,000 | +100.0% | 0.44% | – |
| LHCG | Sell | LHC GROUP INC | $3,073,000 | +21.8% | 14,457 | -0.1% | 0.32% | +7.1% |
| NNOX | New | NANO X IMAGING LTD | $2,481,000 | – | 105,500 | +100.0% | 0.25% | – |
| PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $2,283,000 | +9.1% | 17,285 | 0.0% | 0.23% | -4.1% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $2,271,000 | +13.2% | 7,580 | 0.0% | 0.23% | -0.4% | |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,263,000 | -0.9% | 16,713 | 0.0% | 0.23% | -12.8% | |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,924,000 | +5.4% | 18,241 | 0.0% | 0.20% | -7.5% | |
| ABBV | ABBVIE | $524,000 | -10.7% | 5,981 | 0.0% | 0.05% | -20.6% | |
| DYN | New | DYNE THERAPEUTICS INC | $505,000 | – | 25,000 | +100.0% | 0.05% | – |
| MRK | MERCK & CO INC | $352,000 | +7.3% | 4,247 | 0.0% | 0.04% | -5.3% | |
| SNY | SANOFI-SYNTHELABO | $334,000 | -1.5% | 6,650 | 0.0% | 0.03% | -15.0% | |
| DYNT | Buy | DYNATRONICS CORP | $324,000 | -19.2% | 461,675 | +1.3% | 0.03% | -29.8% |
| JNJ | JOHNSON AND JOHNSON | $322,000 | +5.9% | 2,161 | 0.0% | 0.03% | -5.7% | |
| PFE | PFIZER INC | $311,000 | +12.3% | 8,469 | 0.0% | 0.03% | 0.0% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $307,000 | -0.6% | 3,535 | 0.0% | 0.03% | -13.9% | |
| BIO | BIO RAD LABS INC | $282,000 | +14.2% | 548 | 0.0% | 0.03% | 0.0% | |
| AMGN | AMGEN INC | $278,000 | +7.8% | 1,092 | 0.0% | 0.03% | -6.7% | |
| BAX | BAXTER INTERNATIONAL INC | $262,000 | -6.8% | 3,258 | 0.0% | 0.03% | -18.2% | |
| A | AGILENT TECHNOLOGIES INC | $257,000 | +14.2% | 2,548 | 0.0% | 0.03% | 0.0% | |
| HOLX | New | HOLOGIC INC | $222,000 | – | 3,340 | +100.0% | 0.02% | – |
| UNH | UNITEDHEALTH GROUP INC | $216,000 | +5.9% | 692 | 0.0% | 0.02% | -8.3% | |
| ANTM | ANTHEM INC COM | $214,000 | +2.4% | 795 | 0.0% | 0.02% | -8.3% | |
| GRFS | GRIFOLS SA SPONSORED ADR CLASS B | $176,000 | -4.9% | 10,166 | 0.0% | 0.02% | -18.2% | |
| HRC | Exit | HILL-ROM HOLDINGS INC | $0 | – | -2,121 | -100.0% | -0.03% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLC | $0 | – | -5,100 | -100.0% | -0.07% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -45,192 | -100.0% | -0.59% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -129,832 | -100.0% | -0.89% | – |
| ADVM | Exit | ADVERIUM BIOTECHNOLOGIES INC | $0 | – | -469,798 | -100.0% | -1.14% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -103,310 | -100.0% | -1.48% | – |
| HGEN | Exit | HUMANIGEN INC | $0 | – | -4,022,988 | -100.0% | -1.80% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -128,138 | -100.0% | -1.81% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS INC | $0 | – | -294,316 | -100.0% | -2.16% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -2,348,799 | -100.0% | -2.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.